Literature DB >> 21075203

Oxidatively generated DNA damage after Cu(II) catalysis of dopamine and related catecholamine neurotransmitters and neurotoxins: Role of reactive oxygen species.

Wendy A Spencer1, Jeyaprakash Jeyabalan, Sunita Kichambre, Ramesh C Gupta.   

Abstract

There is increasing evidence supporting a causal role for oxidatively damaged DNA in neurodegeneration during the natural aging process and in neurodegenerative diseases such as Parkinson and Alzheimer. The presence of redox-active catecholamine neurotransmitters coupled with the localization of catalytic copper to DNA suggests a plausible role for these agents in the induction of oxidatively generated DNA damage. In this study we have investigated the role of Cu(II)-catalyzed oxidation of several catecholamine neurotransmitters and related neurotoxins in inducing oxidatively generated DNA damage. Autoxidation of all catechol neurotransmitters and related congeners tested resulted in the formation of nearly a dozen oxidation DNA products resulting in a decomposition pattern that was essentially identical for all agents tested. The presence of Cu(II), and to a lesser extent Fe(III), had no effect on the decomposition pattern but substantially enhanced the DNA product levels by up to 75-fold, with dopamine producing the highest levels of unidentified oxidation DNA products (383±46 adducts/10(6) nucleotides), nearly 3-fold greater than 8-oxo-7,8-dihydro-2'-deoxyguanosine (122±19 adducts/10(6) nucleotides) under the same conditions. The addition of sodium azide, 2,2,6,6-tetramethyl-4-piperidone, tiron, catalase, bathocuproine, or methional to the dopamine/Cu(II) reaction mixture resulted in a substantial decrease (>90%) in oxidation DNA product levels, indicating a role for singlet oxygen, superoxide, H(2)O(2), Cu(I), and Cu(I)OOH in their formation. Whereas the addition of N-tert-butyl-α-phenylnitrone significantly decreased (67%) dopamine-mediated oxidatively damaged DNA, three other hydroxyl radical scavengers, ascorbic acid, sodium benzoate, and mannitol, had little to no effect on these oxidation DNA product levels, suggesting that free hydroxyl radicals may have limited involvement in this dopamine/Cu(II)-mediated oxidatively generated DNA damage. These studies suggest a possible contributory role of oxidatively generated DNA damage by dopamine and related catechol neurotransmitters/neurotoxins in neurodegeneration and cell death. We also found that a naturally occurring broad-spectrum antioxidant, ellagic acid, was substantially effective (nearly 50% inhibition) at low doses (1μM) at preventing this dopamine/Cu(II)-mediated oxidatively generated DNA damage. Because dietary ellagic acid has been found to reduce oxidative stress in rat brains, a neuroprotective role of this polyphenol is plausible. Copyright Â
© 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21075203      PMCID: PMC3353411          DOI: 10.1016/j.freeradbiomed.2010.10.693

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  61 in total

1.  Mitochondrial DNA damage as a mechanism of cell loss in Alzheimer's disease.

Authors:  S M de la Monte; T Luong; T R Neely; D Robinson; J R Wands
Journal:  Lab Invest       Date:  2000-08       Impact factor: 5.662

2.  Formation of DNA adducts and oxidative base damage by copper mediated oxidation of dopamine and 6-hydroxydopamine.

Authors:  G Lévay; Q Ye; W J Bodell
Journal:  Exp Neurol       Date:  1997-08       Impact factor: 5.330

3.  Tyrosinase enhances the covalent modification of DNA by dopamine.

Authors:  A H Stokes; B G Brown; C K Lee; D J Doolittle; K E Vrana
Journal:  Brain Res Mol Brain Res       Date:  1996-11

4.  Modulation of novel DNA adducts during human uterine cervix cancer progression.

Authors:  Srivani Ravoori; Manicka V Vadhanam; Diane D Davey; Cidambi Srinivasan; Bala Nagarajan; Ramesh C Gupta
Journal:  Int J Oncol       Date:  2006-12       Impact factor: 5.650

5.  Systemic increase of oxidative nucleic acid damage in Parkinson's disease and multiple system atrophy.

Authors:  Akio Kikuchi; Atsushi Takeda; Hiroshi Onodera; Teiko Kimpara; Kinya Hisanaga; Nobuyuki Sato; Akihiko Nunomura; Rudy J Castellani; George Perry; Mark A Smith; Yasuto Itoyama
Journal:  Neurobiol Dis       Date:  2002-03       Impact factor: 5.996

Review 6.  DNA repair, mitochondria, and neurodegeneration.

Authors:  L Weissman; N C de Souza-Pinto; T Stevnsner; V A Bohr
Journal:  Neuroscience       Date:  2006-11-07       Impact factor: 3.590

7.  Oxidative DNA adducts after Cu(2+)-mediated activation of dihydroxy PCBs: role of reactive oxygen species.

Authors:  Wendy A Spencer; Hans-Joachim Lehmler; Larry W Robertson; Ramesh C Gupta
Journal:  Free Radic Biol Med       Date:  2009-02-20       Impact factor: 7.376

8.  Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies.

Authors:  L Lyras; R H Perry; E K Perry; P G Ince; A Jenner; P Jenner; B Halliwell
Journal:  J Neurochem       Date:  1998-07       Impact factor: 5.372

9.  Mechanism of metal-mediated DNA damage and apoptosis induced by 6-hydroxydopamine in neuroblastoma SH-SY5Y cells.

Authors:  Hatasu Kobayashi; Shinji Oikawa; So Umemura; Iwao Hirosawa; Shosuke Kawanishi
Journal:  Free Radic Res       Date:  2008-07

10.  Intense oxidative DNA damage promoted by L-dopa and its metabolites. Implications for neurodegenerative disease.

Authors:  J P Spencer; A Jenner; O I Aruoma; P J Evans; H Kaur; D T Dexter; P Jenner; A J Lees; D C Marsden; B Halliwell
Journal:  FEBS Lett       Date:  1994-10-24       Impact factor: 4.124

View more
  18 in total

Review 1.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

2.  Copper-mediated DNA damage by the neurotransmitter dopamine and L-DOPA: A pro-oxidant mechanism.

Authors:  Nida Rehmani; Atif Zafar; Hussain Arif; Sheikh Mumtaz Hadi; Altaf A Wani
Journal:  Toxicol In Vitro       Date:  2017-01-28       Impact factor: 3.500

Review 3.  The neuroprotective effects of glucagon-like peptide 1 in Alzheimer's and Parkinson's disease: An in-depth review.

Authors:  Niklas Reich; Christian Hölscher
Journal:  Front Neurosci       Date:  2022-09-01       Impact factor: 5.152

4.  SLC6A3 is a risk factor for Parkinson's disease: a meta-analysis of sixteen years' studies.

Authors:  Desheng Zhai; Songji Li; Ying Zhao; Zhicheng Lin
Journal:  Neurosci Lett       Date:  2013-11-07       Impact factor: 3.046

5.  Norepinephrine Reduces Reactive Oxygen Species (ROS) and DNA Damage in Ovarian Surface Epithelial Cells.

Authors:  Pooja R Patel; Muralidhar L Hegde; Jacob Theruvathu; Sankar A Mitra; Istvan Boldogh; Lawrence Sowers
Journal:  J Bioanal Biomed       Date:  2015

Review 6.  Copper and copper proteins in Parkinson's disease.

Authors:  Sergio Montes; Susana Rivera-Mancia; Araceli Diaz-Ruiz; Luis Tristan-Lopez; Camilo Rios
Journal:  Oxid Med Cell Longev       Date:  2014-01-08       Impact factor: 6.543

7.  Hydrogen peroxide generated by xanthine/xanthine oxidase system represses the proliferation of colorectal cancer cell line Caco-2.

Authors:  Satoru Sakuma; Muneyuki Abe; Tetsuya Kohda; Yohko Fujimoto
Journal:  J Clin Biochem Nutr       Date:  2014-11-28       Impact factor: 3.114

8.  Ellagic acid inhibits melanoma growth in vitro.

Authors:  J Daniel Jensen; Jeffrey H Dunn; Yuchun Luo; Weimin Liu; Mayumi Fujita; Robert P Dellavalle
Journal:  Dermatol Reports       Date:  2011-12-12

Review 9.  Redox Signaling in Neurotransmission and Cognition During Aging.

Authors:  Ashok Kumar; Brittney Yegla; Thomas C Foster
Journal:  Antioxid Redox Signal       Date:  2017-05-31       Impact factor: 8.401

Review 10.  Research progress on the anticarcinogenic actions and mechanisms of ellagic acid.

Authors:  Hong-Mei Zhang; Lei Zhao; Hao Li; Hao Xu; Wen-Wen Chen; Lin Tao
Journal:  Cancer Biol Med       Date:  2014-06       Impact factor: 4.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.